Search
forResearch 10 of 359
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Dermatologic Reactions to Targeted Therapy
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →